Cigna has updated its coverage policy to remove prior restrictions on home phototherapy, effective July 15, 2025.
This change opens access for Cigna’s 19.2 million covered lives nationwide, allowing eligible members with conditions such as psoriasis, eczema, and vitiligo to receive treatment at home without unnecessary coverage limitations.
This move follows a similar recent coverage decision by Elevance Health/Anthem, which covers 47.5 million people.
With both Cigna and Elevance now covering home phototherapy without restrictions, more than 66.7 million insured Americans have expanded access to a safe, non-invasive treatment clinically proven to achieve clearance or significant improvement in up to 80% of patients.
“With both Cigna and Elevance now on board, this is a watershed moment for dermatologic care,” says Padma Sundar, Chief Commercial Officer at Phothera, in a news release announcing the move. “Millions more patients can now receive proven, effective treatment in the comfort of their own home—without unnecessary cost or access barriers. We remain committed to ensuring cost is never a barrier to treatment—working directly with insurance providers for coverage and offering financial assistance to eligible patients.”
